THE Australian Influenza Vaccine Committee has issued its recommendations for viruses to be included in influenza vaccines in the 2019 southern hemisphere influenza season.
For egg-based quadrivalent influenza vaccines the constituents include an A/Michigan/45/2015 (1N1) pdm0-9-like virus; an A/Switzerland/8060/2017 (H3N2)-like virus; a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage); and a B/Phuket/3073/2013-like virus (B/Yamagata/16/188 lineage).
Egg-based trivalent vaccines will have the A/Michigan, A/Switzerland and B/Phuket-like viruses, and non egg-based vaccines will have an A/Singapore/INFMH-16-0019/2016 (H3N2)-like virus along with the other components indicated for egg based vaccines.
The Therapeutic Goods Administration has accepted the committee's recommendations.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 18
